Do high-dose corticosteroids improve outcomes in hospitalized COVID-19 patients?
Observational Study
[키워드] 95% CI
95% confidence interval
Acute kidney injury
Admission
Adult patient
AKI
characterized
Coronavirus disease 2019
Corticosteroid
Corticosteroids
COVID-19
COVID-19 admission
criteria
death
decrease
died
discharged
dose
dysregulated
excluded
HAI
Hemodialysis
High dose
High-dose
higher odd
hospitalized COVID-19
hyperimmune response
IMPROVE
IMV
in-hospital mortality
Infection
Invasive mechanical ventilation
inverse
less
median
Methylprednisolone
Mortality
observation
Odds ratio
outcome
outcomes
Patient
Probability
retrospective
shown
Standard dose
steroid
was used
[DOI] 10.1002/jmv.27357 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1002/jmv.27357 PMC 바로가기 [Article Type] Observational Study